
Reset all filters
01 2Viekira
02 3Viekira Pak
Ombitasvir, Paritaprevir, Ritonavir
Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...
Currency : USD
2015 Revenue in Millions : 48
2014 Revenue in Millions : 1,639
Growth (%) : 3315%
Ombitasvir, Paritaprevir, Ritonavir
Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...
Currency : USD
2016 Revenue in Millions : 1,522
2015 Revenue in Millions : 1,639
Growth (%) : -7
Ombitasvir, Paritaprevir, Ritonavir
Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...
Currency : USD
2018 Revenue in Millions : 178
2017 Revenue in Millions : 0
Growth (%) : New Launch
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2019 Revenue in Millions : 36
2018 Revenue in Millions : 178
Growth (%) : -80
Ombitasvir, Paritaprevir, Ritonavir
Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...
Currency : USD
2014 Revenue in Millions :
2013 Revenue in Millions :
Growth (%) :